LDLR and diabetes mellitus: Patients with mutations in APOB, with a less severe phenotype, had a higher prevalence of T2DM (1.91%) than LDLR mutation carriers, and amongst these, the most severe phenotype (receptor-negative) had the lowest prevalence of DM (1.12%) [26].